Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (Q1)Feb 28, 2026 | (FY)Nov 30, 2025 | (Q4)Nov 30, 2025 | (Q3)Aug 31, 2025 | (Q2)May 31, 2025 | (Q1)Feb 28, 2025 | (FY)Nov 30, 2024 | (Q4)Nov 30, 2024 | (Q3)Aug 31, 2024 | (Q2)May 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -70.83%318K | 1,033.73%5.75M | 268.64%2.08M | 252.60%1.06M | 20.24%1.52M | -6.68%1.09M | -90.64%507K | -206.01%-1.23M | -141.49%-692K | -38.17%1.27M |
| Net income from continuing operations | -272.86%-3.43M | 56.19%-9.88M | 77.28%-2.98M | 36.33%-1.88M | -9.91%-4.1M | 66.52%-921K | -335.91%-22.55M | -130.00%-13.13M | -416.33%-2.95M | -2,032.57%-3.73M |
| Operating gains losses | ---- | -64.91%1.52M | ---- | ---- | ---- | ---- | 1,549.43%4.34M | --4.17M | ---- | ---- |
| Depreciation and amortization | -88.41%130K | -88.32%560K | -363.22%-2.83M | 220.80%1.09M | -63.41%1.17M | -20.87%1.12M | -23.83%4.79M | -1.92%1.07M | -137.03%-904K | 145.29%3.21M |
| Asset impairment expenditure | ---- | --0 | ---- | ---- | ---- | ---- | --6.02M | ---- | ---- | ---- |
| Unrealized gains and losses of investment securities | ---- | ---- | ---- | -981.82%-119K | --0 | --0 | --0 | 2,133.33%61K | ---11K | ---56K |
| Remuneration paid in stock | -10.53%34K | 20.56%909K | -2.70%36K | -92.62%35K | 1,026.76%800K | -77.91%38K | -74.49%754K | -97.88%37K | 315.79%474K | -90.84%71K |
| Deferred tax | ---- | --0 | ---- | ---- | ---- | ---- | -494.47%-1.5M | ---- | ---- | ---- |
| Other non cashItems | 5.74%1.73M | -73.12%5.27M | -114.63%-863K | -66.74%1.21M | -36.22%3.29M | -66.73%1.64M | 1,026.61%19.61M | 807.23%5.9M | 216.32%3.64M | 1,153.53%5.15M |
| Change In working capital | 335.83%1.86M | 167.24%7.37M | 282.65%7.08M | 164.50%714K | 110.78%364K | 69.73%-787K | -488.96%-10.96M | -241.39%-3.87M | -184.70%-1.11M | -37,411.11%-3.38M |
| -Change in receivables | -6.76%1.39M | 117.81%523K | 44.32%-1.93M | -71.21%241K | 3,336.36%712K | 606.78%1.5M | -249.77%-2.94M | -332.17%-3.46M | -32.55%837K | -103.69%-22K |
| -Change in inventory | 238.75%1.15M | 214.32%5.32M | 3,187.30%6.21M | 14.79%419K | 82.91%-477K | 65.66%-831K | 49.28%-4.66M | 110.00%189K | 108.35%365K | -112.57%-2.79M |
| -Change in prepaid assets | 115.59%70K | -0.83%597K | 11.38%362K | -74.27%88K | 292.88%596K | -284.02%-449K | -18.43%602K | 202.20%325K | -29.92%342K | -177.44%-309K |
| -Change in payables and accrued expense | 24.05%-761K | 123.28%923K | 360.58%2.43M | 98.72%-34K | -83.86%-467K | -676.74%-1M | -142.63%-3.97M | -126.92%-931K | -167.10%-2.65M | -182.20%-254K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -70.83%318K | 1,033.73%5.75M | 268.64%2.08M | 252.60%1.06M | 20.24%1.52M | -6.68%1.09M | -90.64%507K | -206.01%-1.23M | -141.49%-692K | -38.17%1.27M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -700.00%-16K | 370.51%211K | 93.22%-4K | 1,741.67%221K | 90.00%-4K | -122.22%-2K | 98.89%-78K | 90.78%-59K | 103.23%12K | 97.54%-40K |
| Net PPE purchase and sale | -700.00%-16K | 64.89%-33K | 93.22%-4K | -475.00%-23K | 90.00%-4K | -122.22%-2K | 97.36%-94K | 90.80%-59K | 98.92%-4K | 97.54%-40K |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- |
| Net investment purchase and sale | --0 | --0 | --0 | ---- | ---- | --0 | --16K | --0 | ---- | ---- |
| Net other investing changes | ---- | --244K | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -700.00%-16K | 370.51%211K | 93.22%-4K | 1,741.67%221K | 90.00%-4K | -122.22%-2K | 98.89%-78K | 90.78%-59K | 103.23%12K | 97.54%-40K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 44.07%-1.02M | -1,252.88%-6.21M | -1,369.44%-1.59M | -160.02%-1.44M | -124.38%-1.35M | -58.67%-1.83M | 112.31%539K | 92.55%-108K | 732.63%2.4M | 72.94%-603K |
| Net issuance payments of debt | 44.07%-1.02M | -386.79%-6.01M | -8.07%-1.38M | -161.98%-1.44M | -19.63%-1.35M | -58.67%-1.83M | 70.69%-1.23M | 0.39%-1.28M | 523.27%2.33M | 47.00%-1.13M |
| Net common stock issuance | ---- | --0 | --0 | --0 | ---- | ---- | --2.37M | --1.72M | --142K | ---- |
| Net other financing activities | ---- | 65.50%-207K | ---- | ---- | ---- | ---- | -257.14%-600K | ---550K | ---66K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 44.07%-1.02M | -1,252.88%-6.21M | -1,369.44%-1.59M | -160.02%-1.44M | -124.38%-1.35M | -58.67%-1.83M | 112.31%539K | 92.55%-108K | 732.63%2.4M | 72.94%-603K |
| Net cash flow | ||||||||||
| Beginning cash position | -14.66%1.49M | 125.39%1.74M | -68.32%995K | -18.07%1.16M | 25.41%997K | 125.39%1.74M | -88.59%772K | 84.98%3.14M | 81.43%1.42M | -69.28%795K |
| Current changes in cash | 2.83%-722K | -126.34%-255K | 134.98%490K | -109.63%-166K | -73.63%164K | -3,330.43%-743K | 116.15%968K | -51.30%-1.4M | 88.00%1.72M | 134.42%622K |
| End cash Position | -23.47%763K | -14.66%1.49M | -14.66%1.49M | -68.32%995K | -18.07%1.16M | 25.41%997K | 125.39%1.74M | 125.39%1.74M | 84.98%3.14M | 81.43%1.42M |
| Free cash from | -72.24%302K | 1,325.19%5.72M | 260.26%2.08M | 248.42%1.03M | 23.84%1.52M | -6.85%1.09M | -78.38%401K | -347.80%-1.3M | -153.62%-696K | 190.97%1.23M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.